Xenetic Biosciences (XBIO) Earnings Date & Reports

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XBIO is expected to report earnings to fall 81.36% to -10 cents per share on May 17

Xenetic Biosciences XBIO Stock Earnings Reports

Q1'23

Est.

$-0.11

Q1'25

Beat

by $0.13

Q4'24

Missed

by $0.51

Q4'22

Est.

$-0.10

Q3'22

Est.

$-0.06

The last earnings report on May 13 showed earnings per share of -58 cents, beating the estimate of -72 cents. With 40.95K shares outstanding, the current market capitalization sits at 5.71M.

View a ticker or compare two or three

Compare

XBIO